These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1823317)

  • 21. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.
    Gerencer M; Burek V; Crowe BA; Barrett NP; Dorner F
    Microb Pathog; 1998 Nov; 25(5):253-66. PubMed ID: 9878454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
    Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
    Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 gp120 and immune network.
    Metlas R; Veljkovic V
    Int Rev Immunol; 2004; 23(5-6):413-22. PubMed ID: 15370273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
    Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
    J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct impact of inactivated HIV-1 virions on B lymphocyte subsets.
    Viau M; Veas F; Zouali M
    Mol Immunol; 2007 Mar; 44(8):2124-34. PubMed ID: 17134757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
    Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
    J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 gp120: a novel viral B cell superantigen.
    Townsley-Fuchs J; Neshat MS; Margolin DH; Braun J; Goodglick L
    Int Rev Immunol; 1997; 14(4):325-38. PubMed ID: 9186784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoregulation of tumor necrosis factor production by HIV-1 gp-120 in neonates and adults.
    Nair MP; Sweet AM; Schwartz SA
    Ann N Y Acad Sci; 1993 Oct; 693():309-11. PubMed ID: 8267288
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis.
    Dis Markers; 1991; 9(6):341-2. PubMed ID: 1823316
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV-1 and scrub-typhus.
    Ikeda M; Yoshida S
    Lancet; 2000 Nov; 356(9244):1851. PubMed ID: 11117935
    [No Abstract]   [Full Text] [Related]  

  • 33. TNF alpha regulation of HIV1: biology and therapy.
    Kaplan G; Moreira AL
    Res Immunol; 1994; 145(8-9):685-9; discussion 689-90. PubMed ID: 7754220
    [No Abstract]   [Full Text] [Related]  

  • 34. gp120- and TNF-alpha-induced modulation of human B cell function: proliferation, cyclic AMP generation, Ig production, and B-cell receptor expression.
    Patke CL; Shearer WT
    J Allergy Clin Immunol; 2000 May; 105(5):975-82. PubMed ID: 10808179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion.
    Clouse KA; Cosentino LM; Weih KA; Pyle SW; Robbins PB; Hochstein HD; Natarajan V; Farrar WL
    J Immunol; 1991 Nov; 147(9):2892-901. PubMed ID: 1918997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
    Herbeuval JP; Shearer GM
    AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant gp120 specifically enhances tumour necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.
    Dis Markers; 1991; 9(6):342-4. PubMed ID: 1823317
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.
    Rieckmann P; Poli G; Fox CH; Kehrl JH; Fauci AS
    J Immunol; 1991 Nov; 147(9):2922-7. PubMed ID: 1918999
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.